Valeo Pharma Inc. announced the appointment of Mr. Frederic Fasano to the newly created position of President and Chief Operating Officer, effective January 18th, to augment its senior leadership team and support expansion of Valeo's commercial activities. Mr. Fasano has also been elected to the Company's Board of Directors effective as of January 18, 2021. In addition to continuing in his role as CEO of Valeo, Mr. Saviuk will assume the role of Vice-Chairman of Valeo's Board of Directors. Mr. Richard MacKay remains Chairman of the Board.